Pascale Witz
Insider Reports History
- Location
- Waltham, MA
- Signature
- /s/ Christopher Aker, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Pascale Witz:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REVVITY, INC. | Director | Common Stock | 13,705 | $1,274,839 | $93.02 | 30 Apr 2025 | Direct |
| Regulus Therapeutics Inc. | Director | Common Stock | 0 | $0 | $7.93 | 25 Jun 2025 | Direct |
| Horizon Therapeutics Public Ltd Co | Director | Ordinary Shares | 0 | $116.50 | 06 Oct 2023 | By Trust | |
| Horizon Therapeutics Public Ltd Co | Director | Ordinary Shares | 0 | $116.50 | 06 Oct 2023 | Direct | |
| Horizon Therapeutics Public Ltd Co | Director | Restricted Stock Units | 0 | 06 Oct 2023 | Direct | ||
| Horizon Therapeutics Public Ltd Co | Director | Stock Option (Right to Buy) | 0 | 06 Oct 2023 | Direct | ||
| Regulus Therapeutics Inc. | Director | Class A-2 Convertible Preferred Stock | 0 | 25 Jun 2025 | Direct | ||
| Regulus Therapeutics Inc. | Director | Stock Option | 0 | 25 Jun 2025 | Direct |